Mark Sorenson

Dr. Sorenson is Head of CMC Development at Curtana Pharmaceuticals. He brings over 25 years of experience in the pharmaceutical industry to Curtana. Dr. Sorenson has extensive experience consulting for pharmaceutical companies where he provides Chemistry, Manufacturing and Controls (CMC) leadership associated with the development of small molecule new chemical entities. His areas of expertise include analytical method development/validation and transfers, stability programs and data assessment, chemical process development, formulation and process development, API and drug product manufacturing and CMC regulatory document preparation. He previously held positions of increasing responsibility at Agouron Pharmaceuticals, Warner Lambert, Pfizer, and MGI Pharma. Dr. Sorenson earned his Ph.D. in Pharmaceutics and B.S. in Pharmacy at the University of Minnesota.